Carmen M. Anadon

ORCID: 0000-0002-8851-4545 · 2 papers in corpus · active 2022-2023

Study types

  • article 2

Condition tags

  • endometriosis 2
article 2023
Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma
Gynecologic oncology ·doi:10.1016/j.ygyno.2023.03.020

OBJECTIVE: To demonstrate that shared antibody responses in endometriosis and endometriosis-associated ovarian cancer spontaneously antagonize malignant progression and can be leveraged to develop future immunotherapies. METHODS: B cells f…

article 2022
Utilization of immortalized B cells to identify SDCBP as a novel therapeutic target in ovarian carcinoma.
·doi:10.1200/jco.2022.40.16_suppl.e14507

e14507 Background: We hypothesized that tumor-infiltrating B cells in endometriosis and endometriosis-associated ovarian cancer can be used to identify novel, targetable antigen domains to inhibit the progression of ovarian carcinomas. We a…